Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability. | Sci China Life Sci | 2022 | 35266112 | PubTator, text mining | PubMed |
| Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. | NAR Cancer | 2022 | 35252869 | PubTator, text mining | PubMed |
| The importance of miRNA-630 in human diseases with an especial focus on cancers. | Cancer Cell Int | 2022 | 35248081 | PubTator, text mining | PubMed |
| Global analysis of miRNA-mRNA regulation pair in bladder cancer. | World J Surg Oncol | 2022 | 35241117 | PubTator, text mining | PubMed |
| Modulation of miRISC-Mediated Gene Silencing in Eukaryotes. | Front Mol Biosci | 2022 | 35237661 | PubTator, text mining | PubMed |
| The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer Progression. | J Oncol | 2022 | 35237319 | PubTator, text mining | PubMed |
| The long and short non-coding RNAs modulating EZH2 signaling in cancer. | J Hematol Oncol | 2022 | 35236381 | PubTator, text mining | PubMed |
| CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities. | Cell Rep | 2022 | 35235778 | PubTator, text mining | PubMed |
| CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma. | Front Mol Biosci | 2022 | 35223991 | PubTator, text mining | PubMed |
| Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer. | Oxid Med Cell Longev | 2022 | 35222794 | PubTator, text mining | PubMed |
| Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. | J Crohns Colitis | 2022 | 35212366 | PubTator, text mining | PubMed |
| Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers? | Curr Oncol | 2022 | 35200568 | PubTator, text mining | PubMed |
| Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer. | Curr Oncol | 2022 | 35200555 | PubTator, text mining | PubMed |
| Human umbilical cord-mesenchymal stem cells-derived exosomes carrying microRNA-15a-5p possess therapeutic effects on Wilms tumor via regulating septin 2. | Bioengineered | 2022 | 35200105 | PubTator, text mining | PubMed |
| CircRNA_0008194 functions as a ceRNA to promote invasion of hepatocellular carcinoma via inhibiting miR-190a/AHNAK signaling pathway. | J Clin Lab Anal | 2022 | 35199873 | PubTator, text mining | PubMed |
| SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7. | Cell Death Dis | 2022 | 35197448 | PubTator, text mining | PubMed |
| lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head. | J Healthc Eng | 2022 | 35190765 | PubTator, text mining | PubMed |
| A curious case of cyclin-dependent kinases in neutrophils. | J Leukoc Biol | 2022 | 35188696 | PubTator, text mining | PubMed |
| Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling. | Front Mol Biosci | 2022 | 35187083 | PubTator, text mining | PubMed |
| Determining The Role of MicroRNAs in Self-Renewal, Metastasis and Resistance to Drugs in Human Gastric Cancer Based on Data Mining Approaches: A Systematic Review. | Cell J | 2022 | 35182058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=38